$4.98 Billion is the total value of GREEN VALLEY INVESTORS LLC's 25 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Buy | Gilead Sciences Inc | $294,390,000 | +24.9% | 3,000,000 | +20.0% | 5.91% | +19.1% |
| LKQ | Buy | LKQ Corp | $199,368,000 | +33.8% | 7,800,000 | +47.2% | 4.00% | +27.6% |
| VRX | Buy | Valeant Pharmaceuticals International Inc | $158,896,000 | +158.7% | 800,000 | +86.4% | 3.19% | +146.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| JOHNSON & JOHNSON | 26 | Q3 2019 | 8.8% |
| WAL-MART STORES INC | 26 | Q3 2019 | 5.4% |
| ABBOTT LABS | 26 | Q3 2019 | 7.7% |
| STRYKER CORP | 26 | Q3 2019 | 5.3% |
| TJX COS INC NEW | 26 | Q3 2019 | 4.7% |
| MARRIOTT INTL INC NEW | 26 | Q3 2019 | 4.3% |
| THERMO FISHER SCIENTIFIC INC | 26 | Q3 2019 | 5.6% |
| Air Products & Chemicals Inc | 26 | Q3 2019 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 26 | Q3 2019 | 4.9% |
| CELGENE CORP | 24 | Q1 2019 | 11.3% |
View GREEN VALLEY INVESTORS LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2019-11-13 |
| 13F-HR | 2019-08-12 |
| 13F-HR | 2019-05-13 |
| 13F-HR | 2019-02-13 |
| 13F-HR | 2018-11-13 |
| 13F-HR | 2018-08-10 |
| 13F-HR | 2018-05-09 |
| 13F-HR | 2018-02-13 |
| 13F-HR | 2017-11-13 |
| 13F-HR | 2017-08-10 |
View GREEN VALLEY INVESTORS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.